Tech Company Financing Transactions
Nanology Labs Funding Round
Nanology Labs, based in Toronto ON, secured $3 million from FACIT, Creative Destruction Lab and MEDTEQ.
Transaction Overview
Company Name
Announced On
5/18/2021
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Proceeds Purpose
The capital will advance development of T-MX (aka Manganescan), a smart nanomedicine designed to overcome tumor hypoxia, a common cause of resistance in cancer treatment.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
661 University Ave.
Toronto ON, M5G 1M1
Canada
Toronto ON, M5G 1M1
Canada
Phone
Website
Email Address
Overview
Nanology Labs is leveraging a patented polymer-lipid platform technology to develop unique nanoparticles that are actively transported into cells where they release therapeutic and diagnostic payloads including proteins, nucleic acids, drugs, and imaging agents.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mohammad Amini
Chief Scientific Officer
Shirley Wu
VP - Bus. Development
John Reid
VP - Operations
Chanson He
VP - R & D
Azhar Abbasi
Browse more venture capital transactions:
Prev: 5/18/2021: SoftLedger venture capital transaction
Next: 5/18/2021: Code Ocean venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs